Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Weber

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patientsR R Weber, C E McCoy, J A Ziemniak, et al.
Circulation|December 1, 1987
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopamM B Murphy, C E McCoy, R R Weber, et al.
Experimental Eye Research|November 1, 1988
Effects of selective dopamine-1 receptor activation on intraocular pressure in manT A Karnezis, M B Murphy, R R Weber, et al.
Marine Pollution Bulletin|August 16, 2014
Persistent organic pollutants in liver of Brazilian sharpnose shark (Rhizoprionodon lalandii) from southeastern coast of BrazilM J Cascaes, R T Oliveira, M M Ubarana, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patientsR R Weber, C E McCoy, J A Ziemniak, et al.
Circulation|December 1, 1987
Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopamM B Murphy, C E McCoy, R R Weber, et al.
Experimental Eye Research|November 1, 1988
Effects of selective dopamine-1 receptor activation on intraocular pressure in manT A Karnezis, M B Murphy, R R Weber, et al.
Marine Pollution Bulletin|August 16, 2014
Persistent organic pollutants in liver of Brazilian sharpnose shark (Rhizoprionodon lalandii) from southeastern coast of BrazilM J Cascaes, R T Oliveira, M M Ubarana, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Pageof 2